Cullen Michael T. 4
4 · Panbela Therapeutics, Inc. · Filed Oct 6, 2022
Insider Transaction Report
Form 4
Cullen Michael T.
Director
Transactions
- Purchase
Common Stock
2022-10-04+165,000→ 369,576 total(indirect: By Trust) - Purchase
Warrants (right to buy)
2022-10-04+247,000→ 247,000 total(indirect: By Trust)Exercise: $0.30From: 2022-10-04Exp: 2027-10-04→ Common Stock (247,000 underlying)
Holdings
- 216,811
Common Stock
Footnotes (1)
- [F1]Reported securities purchased as one share of common stock and one warrant to purchase one share of common stock for a combined price of $0.30 per share and warrant.